深度 | 再鼎医药融资上瘾,累计亏损超20亿美元

财中社
19 Nov 2024

连续亏损的创新药企再鼎医药(09688,ZLAB)又开始伸手向市场要钱。11月15日,再鼎医药发布公告,计划发售784万股美国存托股份,代表7843万股相关股份,发售价为每股25.5美元。此次发售预计在2024年11月18日交割,假设期权全部行使,将增加公司普通股约9.06%。若不行使期权,则相关股份占现有已发行普通股约8.30%。公告指出,此次发售所得款项预计在2亿美元至2.3亿美元,净额预计在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10